A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults
- PMID: 22347487
- PMCID: PMC3275565
- DOI: 10.1371/journal.pone.0031500
A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults
Abstract
Attention deficit/hyperactivity disorder (ADHD) is the most prevalent childhood psychiatric condition. It frequently persists into adulthood and can have serious health and other adverse consequences. The majority of previous adult ADHD studies have focused on young adults so that relatively little is known about ADHD symptoms and their effects in mid and late life. In addition, effects of subclinical levels of attention deficit and hyperactivity have not been studied in detail. In this study we investigated ADHD symptoms and related impairment in a large population-based sample of middle-aged Australian adults (n = 2091; 47% male). Applying the WHO adult ADHD Self Report Screener (ASRS) we observed that 6.2% of participants had scores that were previously associated with ADHD diagnosis. No significant gender difference in the distribution of ASRS scores was observed. Multiple regression analyses indicated strong positive correlations between symptoms of ADHD and depression/anxiety and significant negative associations (p<0.01) with employment, financial stress, relationship quality, health and well-being measures in this age group. Importantly, associations were highly significant even when few ADHD symptoms were reported. Compared to the hyperactivity component, the inattention trait was particularly strongly associated and remained significant after controlling for depression/anxiety symptoms. Our study confirms previous findings and significantly adds to existing literature especially for an age-group that has not been well-studied. Our results suggest that ADHD symptoms continue to be associated with ill-health and functional impairment in mid-life and are, therefore, likely to be a major, previously unrecognized source of late-life morbidity with associated social and economic costs. Thus, there is a compelling need for better understanding and development of age-appropriate approaches to the diagnosis and treatment of ADHD in mid- to late-life.
Conflict of interest statement
Figures
Similar articles
-
Attention-deficit/hyperactivity disorder symptoms in adults with self-reported epilepsy: Results from a national epidemiologic survey of epilepsy.Epilepsia. 2015 Feb;56(2):218-24. doi: 10.1111/epi.12897. Epub 2015 Jan 15. Epilepsia. 2015. PMID: 25594106
-
Childhood and adult attention deficit hyperactivity disorder symptoms in fibromyalgia: associations with depression, anxiety and disease impact.Int J Psychiatry Clin Pract. 2020 Sep;24(3):257-263. doi: 10.1080/13651501.2020.1764585. Epub 2020 May 13. Int J Psychiatry Clin Pract. 2020. PMID: 32401570
-
Relationship of attention-deficit-hyperactivity disorder symptoms, depressive/anxiety symptoms, and life quality in young men.Psychiatry Clin Neurosci. 2008 Aug;62(4):421-6. doi: 10.1111/j.1440-1819.2008.01830.x. Psychiatry Clin Neurosci. 2008. PMID: 18778439
-
Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults.Encephale. 2020 Feb;46(1):30-40. doi: 10.1016/j.encep.2019.06.005. Epub 2019 Oct 11. Encephale. 2020. PMID: 31610922 Review.
-
[Awareness of adult attention-deficit/hyperactivity disorder (ADHD) in Greece].Psychiatriki. 2012 Jun;23 Suppl 1:60-5. Psychiatriki. 2012. PMID: 22796974 Review. Greek, Modern.
Cited by
-
Clinical implications of ADHD, ASD, and their co-occurrence in early adulthood-the prospective ABIS-study.BMC Psychiatry. 2023 Nov 16;23(1):851. doi: 10.1186/s12888-023-05298-3. BMC Psychiatry. 2023. PMID: 37974102 Free PMC article.
-
Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.Epidemiol Psychiatr Sci. 2016 Jun;25(3):255-66. doi: 10.1017/S2045796015000360. Epub 2015 May 20. Epidemiol Psychiatr Sci. 2016. PMID: 25989844 Free PMC article.
-
Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine.Neuropsychiatr Dis Treat. 2018 Feb 22;14:611-621. doi: 10.2147/NDT.S150261. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 29503545 Free PMC article.
-
Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.J Child Adolesc Psychopharmacol. 2017 Oct;27(8):690-699. doi: 10.1089/cap.2016.0177. Epub 2017 May 30. J Child Adolesc Psychopharmacol. 2017. PMID: 28557548 Free PMC article. Clinical Trial.
-
Hyperfocus symptom and internet addiction in individuals with attention-deficit/hyperactivity disorder trait.Front Psychiatry. 2023 Mar 16;14:1127777. doi: 10.3389/fpsyt.2023.1127777. eCollection 2023. Front Psychiatry. 2023. PMID: 37009127 Free PMC article.
References
-
- Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366:237–248. - PubMed
-
- Rösler M, Casas M, Konofal E, Buitelaar J. Attention deficit hyperactivity disorder in adults. World J Biol Psychiatry. 2010;11:684–698. - PubMed
-
- Barkley R. Attention Deficit Hyperactivity Disorder in Adults. Sudbury, Massachusetts: Jones and Bartlett Publishers; 2010.
-
- Karam RG, Bau CHD, Salgado CAI, Kalil KLS, Victor MM, et al. Late-onset ADHD in adults: milder, but still dysfunctional. J Psychiatr Res. 2009;43:697–701. - PubMed
-
- Bernfort L, Nordfeldt S, Persson J. ADHD from a socio-economic perspective. Acta Paediatr. 2008;97:239–245. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical